Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor-patient relationship.
Open Access
- 1 November 2003
- journal article
- Published by American Board of Family Medicine (ABFM) in The Journal of the American Board of Family Medicine
- Vol. 16 (6) , 513-524
- https://doi.org/10.3122/jabfm.16.6.513
Abstract
Background:The objective of the study was to determine physicians’ views of the effects of Direct-to-Consumer Advertising (DTCA) on health service utilization, quality of care, and the doctor-patient relationship. Methods:Cross-sectional survey of a nationally representative sample of US physicians to determine their perceptions of the effects of patients discussing information from DTCA on time efficiency; requests for specific interventions; health outcomes; and the doctor-patient relationship. Results:Physicians reported that more than half (56%) of patients who discussed information from DTCA in a visit did so because they wanted a specific intervention, such as a test, change in medication, or specialist referral. The physician deemed 49% of these requests clinically inappropriate. Physicians filled 69% of requests they deemed clinically inappropriate; 39% of physicians perceived DTCA as damaging to the time efficiency of the visit, and 13% saw it as helpful. Thirty-three percent of physicians thought discussing DTCA had improved the doctor-patient relationship; 8% felt it had worsened it. The effect on the relationship was strongly associated with doing what the patient wanted. Conclusions:DTCA can have good and bad effects on quality of care, the doctor-patient relationship, and health service utilization. The benefits might be maximized, and the harms minimized, by increasing the accuracy of information in advertisements; enhancing physicians’ communication and negotiation skills; and encouraging patients to respect physicians’ clinical expertise.Keywords
This publication has 13 references indexed in Scilit:
- Direct Marketing of Pharmaceuticals to ConsumersAnnual Review of Public Health, 2002
- For and against: Direct to consumer advertising is medicalising normal human experience: AgainstBMJ, 2002
- Selling sickness: the pharmaceutical industry and disease mongering * Commentary: Medicalisation of risk factorsBMJ, 2002
- Direct-to-Consumer Advertising — Strengthening Our Health Care SystemNew England Journal of Medicine, 2002
- Promotion of Prescription Drugs to ConsumersNew England Journal of Medicine, 2002
- Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional surveyBMJ, 2002
- Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?The Lancet, 2001
- Direct-to-Consumer Promotion of Prescription DrugsPharmacoEconomics, 2001
- Direct-to-Consumer Prescription Drug Advertising Builds Bridges Between Patients and PhysiciansJAMA, 1999
- Direct-to-Consumer Marketing of Prescription DrugsCreating Consumer DemandJAMA, 1999